Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines

Corporate Breaking News

Home : Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines

Aug 29 2019	Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines
SHANGHAI, Aug. 29, 2019 /PRNewswire/ -- Luye Pharma Group (02186.HK) released its financial results for the first half of 2019 on August 28. The results show the company has achieved a revenue of RMB 3.131 billion, up 42.1% year-on-year; EBITDA reached RMB 1.263 billion, up 44.1%...


Source:https://www.prnewswire.com:443/news-releases/luye-pharma-first-half-of-2019-results-strong-revenue-growth-and-substantial-development-of-rd-product-pipelines-300909022.html

Related News
» Polar King International, Inc. to Showcase Walk-in Refrigeration Equipment at the 141st NGAUS General Conference and Exhibition. » Exadel nawiązuje współpracę z ADAX na rzecz rozwoju zdecentralizowanej giełdy